2010-6 Keluoxin Capsule, the first domestic new traditional Chinese medicine for the treatment of diabetic nephropathy independently developed by the group and with independent intellectual property rights, was included in the 2010 National Key New Product Plan by the Ministry of Science and Technology. 2010-6-3 Kanghong Pharmaceutical Group was awarded the National Enterprise and Institutional Intellectual Property Pilot Unit. 2010-4 According to Guokehuozi No. 2010068, four member companies of Kanghong Pharmaceutical Group (Chengdu Kanghong Pharmaceutical Group Co., Ltd., Chengdu Kanghong Pharmaceutical Co., Ltd., Chengdu Kanghong Biotechnology Co., Ltd. and Sichuan Jishengtang Pharmaceutical Co., Ltd. The company) successfully passed the announcement of the Ministry of Science and Technology and obtained the high-tech enterprise certificate. 2009-4-5 Kanghong Pharmaceutical Group’s trademark was recognized as a well-known trademark in China by the Trademark Office of the State Administration for Industry and Commerce. 2009-1-7 Kanghong Pharmaceutical Group won the 30 Years of Reform and Opening-up Innovation Award at the China Pharmaceutical 30 Years Conference. 2008-10-21 The China Chemical and Pharmaceutical Industry Association awarded the group an AAA enterprise credit rating certificate. As one of the first batch of pharmaceutical enterprise credit evaluation AAA units, the Group is also the only credit-granting enterprise in our province. 2008-9-2 The All-China Federation of Trade Unions awarded Kanghong Guangcai Digital Film and Television’s Disaster Relief and Love Promotion Team the honorary title of Worker Pioneer. At the same time, Ke Zunhong, chairman and president of the group, won the honorary certificate for 5.12 earthquake relief. 2008-4-11 China Chemical and Pharmaceutical Industry Association awarded the group the honorary title of the Sixth Advanced Member Unit of China Chemical and Pharmaceutical Industry Association. At the same time, the group is also the only enterprise in the western region to receive this honor. 2007-9-20 The National Development and Reform Commission issued Announcement No. 50 of 2007, announcing the evaluation scores of nationally recognized enterprise technology centers across the country. Kanghong Pharmaceutical Group successfully passed the review.

2006-9 The Group’s Technology Center was recognized as a national enterprise technology center by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the State Administration of Customs, and the State Administration of Taxation; 2006-2 The Group was awarded the Corporate Director Certificate of the China Hospital Association by the China Hospital Association ; 2005-5 Sichuan Jishengtang Pharmaceutical Co., Ltd. Ganke Shuangqing Capsule was awarded the National Torch Program Project Certificate by the Torch High-tech Industry Development Center of the Ministry of Science and Technology; 2005-5 Chengdu Daxinan Pharmaceutical Co., Ltd. Bosiqing was awarded the Torch Program by the Ministry of Science and Technology The High-tech Industry Development Center awarded the National Torch Plan Project Certificate; 2005-5 Chengdu Kanghong Pharmaceutical Co., Ltd. Songling Xuemaikang Capsules was awarded the National Torch Plan Project Certificate by the Torch High-tech Industrial Development Center of the Ministry of Science and Technology; 2005-1 Chengdu Kanghong Pharmaceutical Co., Ltd. W198 was awarded the First Prize of Science and Technology Progress Award by the Ministry of Education of the People's Republic of China and the Ministry of Education of the People's Republic of China. 2004-12 Chengdu Daxinan Pharmaceutical Co., Ltd. Aripiprazole Tablets was awarded the Science and Technology Progress Award by the Science and Technology Small and Medium Enterprises Technology Innovation Fund Management Center of the Ministry of Science and Technology. Small and medium-sized enterprise technology innovation fund project establishment certificate; 2004-5 Chengdu Daxinan Pharmaceutical Co., Ltd. Xinluona was awarded the national Torch Plan project certificate by the Torch High-tech Industry Development Center of the Ministry of Science and Technology; 2003-7 Chengdu Daxinan Pharmaceutical Co., Ltd. Bellona was awarded the Science and Technology Small and Medium Enterprises Technology Innovation Fund Project Certificate by the Science and Technology Small and Medium Enterprises Technology Innovation Fund Management Center of the Ministry of Science and Technology; 2003-4 Chengdu Kanghong Pharmaceutical Co., Ltd. Yiqing Capsule was awarded the Traditional Chinese Medicine Protected Variety Certificate by the State Food and Drug Administration ; 2000-7 Songling Xuemaikang Capsules and Zhenkening Capsules were awarded national second-level protected traditional Chinese medicine varieties. 2000-5 Bellona was awarded the 2000 National New Product Certificate by the State Economic and Trade Commission; 1998-11 Chengdu Daxinan Pharmaceutical Co., Ltd. Co., Ltd.'s second-class chemical drug Bolexin was awarded the title of national key new product by the Ministry of Science and Technology, the State Administration of Taxation, etc.; 1996-1 Chengdu Kanghong Pharmaceutical Co., Ltd. Songling Xuemaikang Capsule won the academic award at the first Canadian International Traditional Chinese Medicine and Acupuncture Exhibition The first Canadian International Chinese Medicine and Acupuncture Exhibition Gold Medal in 1996 issued by the committee;